當前位置：首頁 JCRQ1 期刊介紹(非官網(wǎng))

International Journal Of Antimicrobial AgentsSCIE

國際簡稱：INT J ANTIMICROB AG 參考譯名：國際抗菌劑雜志

中科院分區(qū)
2區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q1

基本信息：: ISSN：0924-8579; E-ISSN：1872-7913; 是否OA：未開放; 是否預警：否; TOP期刊：是

出版信息：: 出版地區(qū)：NETHERLANDS; 出版商：Elsevier; 出版語言：English; 出版周期：Monthly; 出版年份：1991; 研究方向：醫(yī)學-傳染病學

評價信息：: 影響因子：4.9; H-index：111; CiteScore指數(shù)：21.6; SJR指數(shù)：1.072; SNIP指數(shù)：1.511

發(fā)文數(shù)據(jù)：: Gold OA文章占比：29.37%; 研究類文章占比：88.54%; 年發(fā)文量：253; 自引率：0.0092...; 開源占比：0.1375; 出版撤稿占比：0; 出版國人文章占比：0.08; OA被引用占比：0.0218...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介International Journal Of Antimicrobial Agents期刊介紹

The International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, etc.). In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents. Special attention is given to articles providing insight into the problems of antimicrobial resistance both in the hospital and in the community. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.

期刊簡介International Journal Of Antimicrobial Agents期刊介紹

《International Journal Of Antimicrobial Agents》自1991出版以來，是一本醫(yī)學優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學研究結(jié)果，并為醫(yī)學各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進醫(yī)學領(lǐng)域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學領(lǐng)域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關(guān)注點：

預計審稿時間：一般,3-8周約6.5周
國際TOP期刊
醫(yī)學
INFECTIOUS DISEASES
SCIE
中科院2區(qū)
非預警

Cite Score數(shù)據(jù)（2024年最新版）International Journal Of Antimicrobial Agents Cite Score數(shù)據(jù)

CiteScore：21.6
SJR：1.072
SNIP：1.511

學科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Pharmacology (medical)	Q1	4 / 272	98%
大類：Medicine 小類：Infectious Diseases	Q1	16 / 344	95%
大類：Medicine 小類：Microbiology (medical)	Q1	10 / 140	93%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)International Journal Of Antimicrobial Agents 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區(qū)	小類學科	分區(qū)
醫(yī)學	2區(qū)	INFECTIOUS DISEASES 傳染病學 MICROBIOLOGY 微生物學 PHARMACOLOGY & PHARMACY 藥學	2區(qū) 2區(qū) 2區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運用科學計量學方法對國際、國內(nèi)學術(shù)期刊依據(jù)影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構(gòu)的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)International Journal Of Antimicrobial Agents JCR分區(qū)

2023-2024 年最新版

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：INFECTIOUS DISEASES	SCIE	Q1	16 / 132	88.3%
學科：MICROBIOLOGY	SCIE	Q1	32 / 161	80.4%
學科：PHARMACOLOGY & PHARMACY	SCIE	Q1	45 / 354	87.4%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：INFECTIOUS DISEASES	SCIE	Q1	7 / 132	95.08%
學科：MICROBIOLOGY	SCIE	Q1	11 / 161	93.48%
學科：PHARMACOLOGY & PHARMACY	SCIE	Q1	6 / 354	98.45%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學術(shù)文獻質(zhì)量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
USA195
France142
CHINA MAINLAND121
Spain89
Italy80
Australia71
GERMANY (FED REP GER)71
England62
Netherlands49
Taiwan46

本刊中國學者近年發(fā)表論文

1、Piperacillin/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis
Author: Su, Guobin; Xiao, Cuixia; Cao, Yue; Gao, Peiyan; Xie, Di; Cai, Qingqing; Nie, Sheng; Liu, Xusheng; Lu, Fuhua; Zhou, Yilun; Hu, Ying; Li, Hua; Yang, Qiongqiong; Wan, Qijun; Liu, Bicheng; Xu, Hong; Li, Guisen; Weng, Jianping; Xu, Gang; Chen, Chunbo; Liu, Huafeng; Shi, Yongjun; Zha, Yan; Kong, Yaozhong; Tang, Ying; Shen, Jie; Johnson, David W.; Xu, Xin; Hou, Fan Fan

Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; Vol. 61, Issue 1, pp. -. DOI: 10.1016/j.ijantimicag.2022.106691
2、Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans
Author: Wang, Yuting; Yan, Haiying; Li, Jinfeng; Zhang, Yuan; Wang, Zhen; Sun, Shujuan

Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; Vol. 61, Issue 3, pp. -. DOI: 10.1016/j.ijantimicag.2023.106709
3、The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)
Author: Salmanton-Garcia, Jon; Au, Wing-Yan; Hoenigl, Martin; Chai, Louis Yi Ann; Badali, Hamid; Basher, Ariful; Brockhoff, Ronja A.; Chen, Sharon C. -A.; Chindamporn, Ariya; Chowdhary, Anuradha; Heath, Christopher H.; Jabeen, Kausar; Lee, Jaehyeon; Matar, Madonna; Taj-Aldeen, Saad Jaber; Tan, Ban Hock; Uno, Kenji; Wahyuningsih, Retno; Zhu, Liping; Chakrabarti, Arunaloke; Cornely, Oliver A.

Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; Vol. 61, Issue 3, pp. -. DOI: 10.1016/j.ijantimicag.2023.106718
4、Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate
Author: Li, Siying; Jin, Jie; Jiang, Yi; Shi, Jinfeng; Jiang, Xiaoxian; Lin, Nengming; Ma, Zhiyuan

Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; Vol. 61, Issue 3, pp. -. DOI: 10.1016/j.ijantimicag.2023.106726
5、Individualized vancomycin dosing in infants: prospective evaluation of an online dose calculator
Author: Wilkins, Amanda L.; Lai, Tony; Zhu, Xiao; Bolisetty, Srinivas; Chiletti, Roberto; Cranswick, Noel; Gardiner, Kaya; Hunt, Rodney; Malhotra, Atul; McMullan, Brendan; Mehta, Bhavesh; Michalowski, Joanna; Popat, Himanshu; Ward, Meredith; Duffull, Stephen; Curtis, Nigel; Gwee, Amanda

Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; Vol. 61, Issue 3, pp. -. DOI: 10.1016/j.ijantimicag.2023.106728
6、In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between 2016 and 2019 in China
Author: Yu, Wei; Zhang, Hui; Zhu, Ying; Jia, PeiYao; Xu, YingChun; Yang, QiWen

Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; Vol. 61, Issue 4, pp. -. DOI: 10.1016/j.ijantimicag.2023.106741
7、A single- and multiple-dose study to characterize the pharmacokinetics, safety, and tolerability of ceftolozane/tazobactam in healthy Chinese participants
Author: Liu, Na; Wang, Xiaohong; Zhu, Jixiang; Basu, Sumit; Wei, Yudong; Yan, Bei; Wang, Hui; Colon-Gonzalez, Francheska; Feng, Hwa-Ping; Sun, Fang; Li, Haiyan; Zang, Yanqiao

Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; Vol. 61, Issue 3, pp. -. DOI: 10.1016/j.ijantimicag.2023.106717
8、ICEGpa1804, a novel integrative and conjugative element carrying eight resistance genes, identified in Glaesserella parasuis
Author: Sun, Huarun; Yang, Yingying; Yi, Kaifang; Zhang, Mengke; Luo, Xingwei; He, Dandan; Hu, Gongzheng; Wu, Hua

Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; Vol. 61, Issue 4, pp. -. DOI: 10.1016/j.ijantimicag.2023.106740